Treatment Action Group

TAG symposium: Scale Up to Get Down to Zero TB Deaths, New Infections, and Suffering

2015 Union World Conference on Lung Health
Date: December 4, 2015
Time: 18h00 - 22h30
Location: Southern Sun The Cullinan, 1 Cullinan Street Cape Town Waterfront

Read More →

MSF, TAG symposium: Ending TB in India: Why civil society should dream and act BIG?

2015 Union World Conference on Lung Health, Cape Town, South Africa
Date: December 4, 2015
Time: 17h15-18h30

Read More →

TAG response to the release of the World Health Organization’s 2015 Global tuberculosis report

"In 1993, the World Health Organization declared TB a global emergency. The new data in the WHO's 2015 Global Tuberculosis Report show that all the promises made to end the TB epidemic since 1993 have been hollow. In 2014, 9.6 million people fell ill with TB, and 1.5 million died of it, making TB the world’s leading infectious killer—surpassing HIV. We have made no progress in reducing the incidence of multidrug-resistant TB (MDR-TB), with nearly half a million people developing MDR-TB in 2014, only one-fourth of them detected, and even fewer started on treatment.

Read More →

ACTION ALERT: Urge Johns Hopkins University to accelerate important TB innovation & keep it accessible for all

Take Action for TB Today! Sign and share this petition now: https://uaem.wufoo.com/forms/z1dxtbgq0ieib3a/

Read More →

TB community reiterates request to Johns Hopkins to review sutezolid licensing agreement with Sequella

The TB CAB and TAG restate their request to Johns Hopkins University to allow representatives of TB-affected communities to comment on the terms of any agreement with Sequella before it is finalized.

Read More →

HIV i-Base/TAG: 2015 Pipeline Report

Latest annual review on HIV, HCV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.

Read More →

Letter from TB community re: intellectual property rights to sutezolid

The letter urges Johns Hopkins to assure the timely and responsible development of TB drug candidate sutezolid if transferring any intellectual property rights to Sequella.

Read More →

TB CAB, TAG open letter to the Global Plan Development Task Force

Re: Programmatic and research targets for the Global Plan to Stop TB, 2016–2020

Read More →

TAG open letter to the Global Plan Development Task Force

Re: Inclusion of pediatric-specific targets in the Global Plan to Stop TB, 2016-2020

Read More →

TAG symposium: Zero Accountability: when action doesn't match the numbers - videos now available online

The symposium was held October 30 at the 2014 Union World Conference on Lung Health in Barcelona, Spain.

Read More →

Page 17 of 22 · Total posts: 10

←First 16 17 18 Last→